Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George W Wright

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
The Journal of Experimental Medicine|November 25, 2020
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphomaRaud Razzaghi, Shreya Agarwal, Nikita Kotlov, et al.
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Science Immunology|June 7, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19Mark Roschewski, Michail S Lionakis, Jeff P Sharman, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
The Journal of Experimental Medicine|March 14, 2007
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphomaGeorg Lenz, Inga Nagel, Reiner Siebert, et al.
Immunity|December 3, 2020
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human LymphomasDevin Dersh, James D Phelan, Megan E Gumina, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|November 25, 2020
Compromised counterselection by FAS creates an aggressive subtype of germinal center lymphomaRaud Razzaghi, Shreya Agarwal, Nikita Kotlov, et al.
Cancer Cell|April 15, 2020
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic ImplicationsGeorge W Wright, Da Wei Huang, James D Phelan, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 23, 2014
Blockade of oncogenic IκB kinase activity in diffuse large B-cell lymphoma by bromodomain and extraterminal domain protein inhibitorsMichele Ceribelli, Priscilla N Kelly, Arthur L Shaffer, et al.
Science Immunology|June 7, 2020
Inhibition of Bruton tyrosine kinase in patients with severe COVID-19Mark Roschewski, Michail S Lionakis, Jeff P Sharman, et al.
Cancer Cell|June 21, 2024
IRF4 requires ARID1A to establish plasma cell identity in multiple myelomaArnold Bolomsky, Michele Ceribelli, Sebastian Scheich, et al.
The Journal of Experimental Medicine|March 14, 2007
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphomaGeorg Lenz, Inga Nagel, Reiner Siebert, et al.
Immunity|December 3, 2020
Genome-wide Screens Identify Lineage- and Tumor-Specific Genes Modulating MHC-I- and MHC-II-Restricted Immunosurveillance of Human LymphomasDevin Dersh, James D Phelan, Megan E Gumina, et al.
Cancer Discovery|April 29, 2024
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B-Cell LymphomaSean R Corcoran, James D Phelan, Jaewoo Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 5, 2015
Prognostic Significance of Diffuse Large B-Cell Lymphoma Cell of Origin Determined by Digital Gene Expression in Formalin-Fixed Paraffin-Embedded Tissue BiopsiesDavid W Scott, Anja Mottok, Daisuke Ennishi, et al.
Cancer Cell|May 3, 2024
Molecular targets of glucocorticoids that elucidate their therapeutic efficacy in aggressive lymphomasJaewoo Choi, Michele Ceribelli, James D Phelan, et al.
Pageof 5